{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T22:22:49Z","timestamp":1648592569052},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T00:00:00Z","timestamp":1279670400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00105-010-1996-6","type":"journal-article","created":{"date-parts":[[2010,7,19]],"date-time":"2010-07-19T13:38:25Z","timestamp":1279546705000},"page":"705-718","source":"Crossref","is-referenced-by-count":3,"title":["Antikoagulation in der Dermatologie"],"prefix":"10.1007","volume":"61","author":[{"given":"V.","family":"Meyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.W.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"G\u00f6rge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,21]]},"reference":[{"key":"1996_CR1","doi-asserted-by":"crossref","first-page":"16900","DOI":"10.1073\/pnas.0608207103","volume":"103","author":"Bergmeier","year":"2006","unstructured":"Bergmeier W, Piffath CL, Goerge T et al (2006) The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis. Proc Natl Acad Sci U S A 103(45):16900\u201316905","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1996_CR2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1538-7836.2007.02361.x","volume":"5","author":"Chauhan","year":"2007","unstructured":"Chauhan AK, Goerge T, Schneider SW, Wagner DD (2007) Formation of platelet strings and microthrombi in the presence of ADAMTS-13 inhibitor does not require P-selectin or beta3 integrin. J Thromb Haemost 5(3):583\u2013589","journal-title":"J Thromb Haemost"},{"key":"1996_CR3","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1073\/pnas.0608422104","volume":"104","author":"Schneider","year":"2007","unstructured":"Schneider SW, Nuschele S, Wixforth A et al (2007) Shear-induced unfolding triggers adhesion of von Willebrand factor fibers. Proc Natl Acad Sci U S A 104(19):7899\u20137903","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1996_CR4","first-page":"1","volume":"2","author":"Arnout","year":"2006","unstructured":"Arnout J, Hoylaerts MF, Lijnen HR (2006) Haemostasis. Handb Exp Pharmacol 176 Pt 2:1\u201341","journal-title":"Handb Exp Pharmacol 176 Pt"},{"key":"1996_CR5","doi-asserted-by":"crossref","unstructured":"Butenas S, \u201at Veer C van, Mann KG (1997) Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases. J Biol Chem 22;272(34):21527\u201321533","DOI":"10.1074\/jbc.272.34.21527"},{"key":"1996_CR6","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1200\/JCO.2009.22.6324","volume":"27","author":"Kasthuri","year":"2009","unstructured":"Kasthuri RS, Taubman MB, Mackman N (2009) Role of tissue factor in cancer. J Clin Oncol 27(29):4834\u20134838","journal-title":"J Clin Oncol"},{"key":"1996_CR7","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2353\/ajpath.2007.070104","volume":"171","author":"Tang","year":"2007","unstructured":"Tang H, Ivanciu L, Popescu N et al (2007) Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor. Am J Pathol 171(3):1066\u20131077","journal-title":"Am J Pathol"},{"key":"1996_CR8","unstructured":"Deutsche Gesellschaft f\u00fcr Chirurgie et al (o J) AWMF Leitlinie \u201eProphylaxe der ven\u00f6sen Thromboembolie\u201c (VTE) [Internet]"},{"key":"1996_CR9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000252824","volume":"36","author":"Zaghdoudi","year":"2008","unstructured":"Zaghdoudi I, Rezgui M, Zouaoui W et al (2008) Incidence of deep venous thrombosis in patients with erysipelas of the leg: Prospective study of 30 cases in an emergency department. Pathophysiol Haemost Thromb 36(5):271\u2013274","journal-title":"Pathophysiol Haemost Thromb"},{"key":"1996_CR10","first-page":"352","volume":"128","author":"Perrot","year":"2001","unstructured":"Perrot JL, Perrot S, Laporte Simitsidis S (2001) Is anticoagulant therapy useful when treating erysipelas? Ann Dermatol Venereol 128(3 Pt 2):352\u2013357","journal-title":"Ann Dermatol Venereol"},{"key":"1996_CR11","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/annonc\/mdi165","volume":"16","author":"Falanga","year":"2005","unstructured":"Falanga A, Zacharski L (2005) Deep vein thrombosis in cancer: The scale of the problem and approaches to management. Ann Oncol 16(5):696\u2013701","journal-title":"Ann Oncol"},{"key":"1996_CR12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1067\/mva.2002.123327","volume":"36","author":"Grazziotin","year":"2002","unstructured":"Grazziotin MU, Turnipseed WD (2002) Arterial tumor embolism caused by metastatic melanoma: case report and literature review. J Vasc Surg 36(1):191\u2013193","journal-title":"J Vasc Surg"},{"key":"1996_CR13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00059-009-3253-2","volume":"34","author":"Machnick","year":"2009","unstructured":"Machnick S, Butz T, Bracht M van et al (2009) Multiple cardiac metastases from a malignant melanoma causing consecutive pulmonary embolism. Herz 34(5):410\u2013411","journal-title":"Herz"},{"key":"1996_CR14","first-page":"327","volume":"49","author":"Valente","year":"2001","unstructured":"Valente M, Pozzi-Mucelli F, Ponte E (2001) Venous thromboembolism and melanoma. Minerva Cardioangiol 49(5):327\u2013333","journal-title":"Minerva Cardioangiol"},{"key":"1996_CR15","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00000658-198111000-00016","volume":"194","author":"Arbeit","year":"1981","unstructured":"Arbeit JM, Lowry SF, Line BR et al (1981) Deep venous thromboembolism in patients undergoing inguinal lymph node dissection for melanoma. Ann Surg 194(5):648\u2013655","journal-title":"Ann Surg"},{"key":"1996_CR16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1055\/s-0037-1622224","volume":"36","author":"G\u00f6rge","year":"2008","unstructured":"G\u00f6rge T, Schneider SW (2008) Tumor-induzierte Thrombophilie. Zellbiologische Grundlagen und klinischer Ausblick. Phlebologie 36(3):142\u2013147","journal-title":"Phlebologie"},{"key":"1996_CR17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.burns.2006.02.018","volume":"32","author":"Barret","year":"2006","unstructured":"Barret JP, Dziewulski PG (2006) Complications of the hypercoagulable status in burn injury. Burns 32(8):1005\u20131008","journal-title":"Burns"},{"key":"1996_CR18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0190-9622(99)70061-7","volume":"41","author":"Jung","year":"1999","unstructured":"Jung M, Kippes W, Messer G et al (1999) Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence. J Am Acad Dermatol 41(2 Pt 1):266\u2013268","journal-title":"J Am Acad Dermatol"},{"key":"1996_CR19","doi-asserted-by":"crossref","unstructured":"Hussain SK, Sundquist J, Hemminki K (2010) Incidence trends of squamous cell and rare skin cancers in the swedish national cancer registry point to calendar year and age-dependent increases. J Invest Dermatol (in press)","DOI":"10.1038\/jid.2009.426"},{"key":"1996_CR20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejvs.2004.10.002","volume":"29","author":"Gohel","year":"2005","unstructured":"Gohel MS, Taylor M, Earnshaw JJ et al (2005) Risk factors for delayed healing and recurrence of chronic venous leg ulcers \u2013 an analysis of 1324 legs. Eur J Vasc Endovasc Surg 29(1):74\u201377","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1996_CR21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2340\/00015555-0320","volume":"87","author":"Sommer","year":"2007","unstructured":"Sommer F, Hensen P, Bockenholt B et al (2007) Underlying diseases and co-factors in patients with severe chronic pruritus: a 3-year retrospective study. Acta Derm Venereol 87(6):510\u2013516","journal-title":"Acta Derm Venereol"},{"key":"1996_CR22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ajh.20281","volume":"78","author":"Stinnett","year":"2005","unstructured":"Stinnett JM, Pendleton R, Skordos L et al (2005) Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates. Am J Hematol 78(3):167\u2013172","journal-title":"Am J Hematol"},{"key":"1996_CR23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00105-008-1530-2","volume":"59","author":"Sunderkotter","year":"2008","unstructured":"Sunderkotter C, Groot K de (2008) Therapy of vasculitides and vasculopathies. Hautarzt 59(5):382\u2013393","journal-title":"Hautarzt"},{"key":"1996_CR24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/120347540200600506","volume":"6","author":"Maguiness","year":"2002","unstructured":"Maguiness S, Guenther L (2002) Kasabach-Merritt syndrome. J Cutan Med Surg 6(4):335\u2013339","journal-title":"J Cutan Med Surg"},{"key":"1996_CR25","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1001\/archderm.1988.01670090043009","volume":"124","author":"Auletta","year":"1988","unstructured":"Auletta MJ, Headington JT (1988) Purpura fulminans. A cutaneous manifestation of severe protein C deficiency. Arch Dermatol 124(9):1387\u20131391","journal-title":"Arch Dermatol"},{"key":"1996_CR26","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood.V98.6.1662","volume":"98","author":"Fujikawa","year":"2001","unstructured":"Fujikawa K, Suzuki H, McMullen B, Chung D (2001) Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 98(6):1662\u20131666","journal-title":"Blood"},{"key":"1996_CR27","unstructured":"Deutsche Gesellschaft f\u00fcr Angiologie und weitere AWMF-Mitgliedsgesellschaften (o J). Diagnostik und Therapie der Bein- und Beckenvenenthrombose und Lungenembolie. [Internet]. 01\/2005"},{"key":"1996_CR28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.beha.2004.03.003","volume":"17","author":"Mueller","year":"2004","unstructured":"Mueller RL (2004) First-generation agents: Aspirin, heparin and coumarins. Best Pract Res Clin Haematol 17(1):23\u201353","journal-title":"Best Pract Res Clin Haematol"},{"key":"1996_CR29","first-page":"651","volume":"20","author":"McCarter","year":"1944","unstructured":"McCarter JC, Bingham JB, Meyer OO (1944) Studies on the hemorrhagic agent 3,3\u2019-methylenebis (4-hydroxycoumarin): IV. the pathologic findings after the administration of dicumarol. Am J Pathol 20(3):651\u2013659","journal-title":"Am J Pathol"},{"key":"1996_CR30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/01.CIR.19.1.79","volume":"19","author":"Best","year":"1959","unstructured":"Best CH (1959) Preparation of heparin and its use in the first clinical cases. Circulation 19(1):79\u201386","journal-title":"Circulation"},{"key":"1996_CR31","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199105303242206","volume":"324","author":"Hirsh","year":"1991","unstructured":"Hirsh J (1991) Heparin. N Engl J Med 324(22):1565\u20131574","journal-title":"N Engl J Med"},{"key":"1996_CR32","first-page":"72","volume":"85","author":"Fabris","year":"2000","unstructured":"Fabris F, Luzzatto G, Stefani PM et al (2000) Heparin-induced thrombocytopenia. Haematologica 85(1):72\u201381","journal-title":"Haematologica"},{"key":"1996_CR33","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa0803200","volume":"358","author":"Kishimoto","year":"2008","unstructured":"Kishimoto TK, Viswanathan K, Ganguly T et al (2008) Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 358(23):2457\u20132467","journal-title":"N Engl J Med"},{"key":"1996_CR34","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1177\/10760296990050S113","volume":"5","author":"Mammen","year":"1999","unstructured":"Mammen EF (1999) Low molecular weight heparins and heparin-induced thrombocytopenia. Clin Appl Thromb Hemost 5(Suppl 1):S72\u2013S75","journal-title":"Clin Appl Thromb Hemost"},{"key":"1996_CR35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199603143341101","volume":"334","author":"Levine","year":"1996","unstructured":"Levine M, Gent M, Hirsh J et al (1996) A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 334(11):677\u2013681","journal-title":"N Engl J Med"},{"key":"1996_CR36","unstructured":"Schmid P, Fischer AG, Wuillemin WA (2009) Low-molecular-weight heparin in patients with renal insufficiency. Swiss Med Wkly 139(31\u201332):438\u2013452"},{"key":"1996_CR37","unstructured":"Schinzel H (2007) Einsatz von niedermolekularen Heparinen bei Niereninsuffizienz. Vascular Care 01\/2007:4\u201317"},{"key":"1996_CR38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11239-009-0418-z","volume":"29","author":"Lim","year":"2010","unstructured":"Lim W (2010) Using low molecular weight heparin in special patient populations. J Thromb Thrombolysis 29(2):233\u2013240","journal-title":"J Thromb Thrombolysis"},{"key":"1996_CR39","doi-asserted-by":"crossref","first-page":"88S","DOI":"10.1592\/phco.24.10.88S.36122","volume":"24","author":"Dager","year":"2004","unstructured":"Dager WE, Andersen J, Nutescu E (2004) Special considerations with fondaparinux therapy: heparin-induced thrombocytopenia and wound healing. Pharmacotherapy 24(7 Pt 2):88S\u201394S","journal-title":"Pharmacotherapy"},{"key":"1996_CR40","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/ATVBAHA.110.202978","volume":"30","author":"Perzborn","year":"2010","unstructured":"Perzborn E, Roehrig S, Straub A et al (2010) Rivaroxaban: a new oral factor xa inhibitor. Arterioscler Thromb Vasc Biol 30(3):376\u2013381","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1996_CR41","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/ATVBAHA.109.197178","volume":"30","author":"Schumacher","year":"2010","unstructured":"Schumacher WA, Luettgen JM, Quan ML, Seiffert DA (2010) Inhibition of factor XIa as a new approach to anticoagulation. Arterioscler Thromb Vasc Biol 30(3):388\u2013392","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-010-1996-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-010-1996-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-010-1996-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T03:37:48Z","timestamp":1558582668000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-010-1996-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,21]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["1996"],"URL":"https:\/\/doi.org\/10.1007\/s00105-010-1996-6","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,21]]}}}